Viatris, Mylan Pharmaceuticals and other defendants were slapped with a patent infringement lawsuit Friday in Pennsylvania Western District Court. The lawsuit was brought by Eckert Seamans Cherin & Mellott and Desmarais LLP on behalf of Johnson & Johnson subsidiary Momenta Pharmaceuticals, which asserts two patents related to the injection of medicine to treat multiple sclerosis. Counsel have not yet appeared for the defendants. The case is 2:22-cv-00750, Momenta Pharmaceuticals, Inc. v. Mylan Pharmaceuticals, Inc. et al.

This suit was surfaced by Law.com Radar, a source for high-speed legal news and litigation updates personalized to your practice. Law.com Radar publishes daily updates on just-filed federal cases like this one. Click here to get started and be first to know about new suits in your region, practice area or client sector. Read the complaint here: